MERCK Kommanditgesellschaft auf Aktien
MER
Rang in aandelen
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Aandeelprijs
$171.67
Laatst gesynchroniseerd: 2026-07-13
Marktkapitalisatie
$74.64B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-
Land
DE
Handel MERCK Kommanditgesellschaft auf Aktien (MER)
Categorie
Healthcare
Operationele marge voor MERCK Kommanditgesellschaft auf Aktien (MER)
Operationele marge op 2026 TTM: 0.00%
Volgens de meest recente financiële rapporten en aandelenkoers van MERCK Kommanditgesellschaft auf Aktien is de huidige operationele marge (TTM) 0.00%. Eind 2026 had het bedrijf een operationele marge van 0.00%.
Geschiedenis van de operationele marge van MERCK Kommanditgesellschaft auf Aktien van 2002 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2025 | 19.26% | -6.69% |
| 2024 | 20.64% | 7.17% |
| 2023 | 19.26% | -14.29% |
| 2022 | 22.47% | 3.31% |
| 2021 | 21.75% | 21.04% |
| 2020 | 17.97% | 45.15% |
| 2019 | 12.38% | 4.74% |
| 2018 | 11.82% | -14.60% |
| 2017 | 13.84% | -12.13% |
| 2016 | 15.75% | -4.37% |
| 2015 | 16.47% | 2.55% |
| 2014 | 16.06% | -14.76% |
| 2013 | 18.84% | 15.80% |
| 2012 | 16.27% | 43.73% |
| 2011 | 11.32% | -15.84% |
| 2010 | 13.45% | 17.06% |
| 2009 | 11.49% | -21.84% |
| 2008 | 14.70% | -27.37% |
| 2007 | 20.24% | 29.58% |
| 2006 | 15.62% | 21.37% |
| 2005 | 12.87% | 33.23% |
| 2004 | 9.66% | 20.15% |
| 2003 | 8.04% | 20.18% |
| 2002 | 6.69% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 10.52% | - |
JP
|
|
| 17.08% | - |
CH
|
|
| 22.93% | - |
IN
|
|
| 23.92% | - |
CN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.